Vistry Group Shares Hold Steady as Barclays Upgrades to Neutral

Vistry Group shares remained largely unchanged this morning following a significant upgrade from Barclays analyst Emily Biddulph, who moved the housebuilder from Underweight to Equal Weight whilst lifting the price target from 507p to 715p.

The upgrade marks a notable shift in sentiment towards the FTSE 250 company, driven primarily by an improving funding environment for affordable housing in the UK.

Empfohlener Broker Multi Asset Platform

Social-Trading-Pionier mit Aktien, ETFs, Krypto und CFDs, Copy Trading inklusive. eToro

5.0

Weitere Informationen 50% of retail investor accounts lose money when trading CFDs with this provider.

The Barclays upgrade comes as the brokerage identified potential policy-driven catalysts for the broader UK housing sector. Whilst maintaining Overweight ratings on rivals Bellway and Barratt Redrow, Barclays highlighted that a revived Help to Buy scheme could deliver upside of more than 20% to sector earnings by 2027. The improved social housing funding outlined in the government’s June 2025 Spending Review and November 2025 Autumn Budget is expected to provide near-term support for affordable housebuilding activity, a segment where Vistry has established a strong competitive position.

Despite the upgrade, Biddulph’s Equal Weight rating suggests a cautious stance, with the 715p price target implying minimal upside from current levels. Balance sheet concerns remain a key consideration, with average daily net debt for 2025 running above £700 million against total facilities of £1.1 billion. This leverage profile has kept some analysts wary, even as the company’s operational restructuring efforts gain traction.

Vistry has been actively repurchasing shares throughout early 2026, signalling management confidence in the company’s valuation. On 7 January, the firm bought back 75,000 ordinary shares at prices ranging between 658.80p and 670.80p, with a volume-weighted average of 665.67p. Further repurchases occurred on 22 January with 15,200 shares acquired at an average of 654.08p, and on 9 February with 14,971 shares purchased at 667.63p. All repurchased shares have been cancelled, reducing total voting rights to 320,012,647 and demonstrating a commitment to enhancing shareholder value.

Price Targets

With the stock trading near analyst consensus targets, markets appear to be taking a wait-and-see approach as the company continues its recovery trajectory.